Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Youssef A. Solyman"'
Autor:
Youssef A. Solyman, Shaimaa S. Ibrahim, Mahmoud S. Kamel, Shehab A. Elmansy, Mazen S. Shehata, Ahmed A. Attia, Mohamed M. Kadry, Youssef Y. Mohamed, Ragy A. Fanous, Omar G. Abo Elseoud, Mina Y. George, Mohamed Amer, Mohamed H. Mohamedy
Publikováno v:
Neuropharmacology. 197
Many cancer survivors suffer from chemotherapy-induced cognitive impairment known as ‘Chemobrain’. Doxorubicin -topoisomerase II inhibitor- is widely used in breast cancer, hematological cancers and other neoplasms. However, it is reported to pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5942959af6606771ec87cdfe33e99e81
https://pubmed.ncbi.nlm.nih.gov/34339751
https://pubmed.ncbi.nlm.nih.gov/34339751
